Neurodevelopmental outcomes in congenital hypothyroidism

Comparison of initial T4 dose and time to reach target T4 and TSH

Karin A. Selva, A. Harper, A. Downs, Peter Blasco, Stephen Lafranchi

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Objectives: To compare neurodevelopmental outcomes in severe and moderate congenital hypothyroidism (CH) among 3 different initial L-thyroxine doses and to examine the effect of the time to thyroid function normalization on neurodevelopmental outcomes. Study design: Neurodevelopmental assessments of 31 subjects included the Mullen Scales of Early Learning, Wechsler Preschool and Primary Scale of Intelligence-Revised, Wechsler Intelligence Scale for Children, Wide-Range Achievement Test, and Child Behavioral Checklist. Results: Subjects started on higher initial L-thyroxine doses (50 μg) had full-scale IQ scores 11 points higher than those started on lower (37.5 μg) initial doses. However, verbal IQ, performance IQ, and achievement scores did not differ among the 3 treatment cohorts. Subjects with moderate CH had higher full-scale IQ scores than subjects with severe CH, regardless of the initial treatment dose. Subjects who took longer than 2 weeks to normalize thyroid function had significantly lower cognitive, attention, and achievement scores than those who achieved normal thyroid function at 1 or 2 weeks of therapy. Conclusions: Initial L-thyroxine dose and faster time to normalization of thyroid function are important to optimal neurodevelopmental outcome. In severe CH, it is important to choose an initial dose at the higher end of the recommended range to achieve these goals.

Original languageEnglish (US)
Pages (from-to)775-780
Number of pages6
JournalJournal of Pediatrics
Volume147
Issue number6
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Congenital Hypothyroidism
Thyroid Gland
Thyroxine
Intelligence
Wechsler Scales
Checklist
Therapeutics
Learning

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Neurodevelopmental outcomes in congenital hypothyroidism : Comparison of initial T4 dose and time to reach target T4 and TSH. / Selva, Karin A.; Harper, A.; Downs, A.; Blasco, Peter; Lafranchi, Stephen.

In: Journal of Pediatrics, Vol. 147, No. 6, 12.2005, p. 775-780.

Research output: Contribution to journalArticle

Selva, Karin A. ; Harper, A. ; Downs, A. ; Blasco, Peter ; Lafranchi, Stephen. / Neurodevelopmental outcomes in congenital hypothyroidism : Comparison of initial T4 dose and time to reach target T4 and TSH. In: Journal of Pediatrics. 2005 ; Vol. 147, No. 6. pp. 775-780.
@article{864c4a46016e4673b412094198de1e61,
title = "Neurodevelopmental outcomes in congenital hypothyroidism: Comparison of initial T4 dose and time to reach target T4 and TSH",
abstract = "Objectives: To compare neurodevelopmental outcomes in severe and moderate congenital hypothyroidism (CH) among 3 different initial L-thyroxine doses and to examine the effect of the time to thyroid function normalization on neurodevelopmental outcomes. Study design: Neurodevelopmental assessments of 31 subjects included the Mullen Scales of Early Learning, Wechsler Preschool and Primary Scale of Intelligence-Revised, Wechsler Intelligence Scale for Children, Wide-Range Achievement Test, and Child Behavioral Checklist. Results: Subjects started on higher initial L-thyroxine doses (50 μg) had full-scale IQ scores 11 points higher than those started on lower (37.5 μg) initial doses. However, verbal IQ, performance IQ, and achievement scores did not differ among the 3 treatment cohorts. Subjects with moderate CH had higher full-scale IQ scores than subjects with severe CH, regardless of the initial treatment dose. Subjects who took longer than 2 weeks to normalize thyroid function had significantly lower cognitive, attention, and achievement scores than those who achieved normal thyroid function at 1 or 2 weeks of therapy. Conclusions: Initial L-thyroxine dose and faster time to normalization of thyroid function are important to optimal neurodevelopmental outcome. In severe CH, it is important to choose an initial dose at the higher end of the recommended range to achieve these goals.",
author = "Selva, {Karin A.} and A. Harper and A. Downs and Peter Blasco and Stephen Lafranchi",
year = "2005",
month = "12",
doi = "10.1016/j.jpeds.2005.07.024",
language = "English (US)",
volume = "147",
pages = "775--780",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Neurodevelopmental outcomes in congenital hypothyroidism

T2 - Comparison of initial T4 dose and time to reach target T4 and TSH

AU - Selva, Karin A.

AU - Harper, A.

AU - Downs, A.

AU - Blasco, Peter

AU - Lafranchi, Stephen

PY - 2005/12

Y1 - 2005/12

N2 - Objectives: To compare neurodevelopmental outcomes in severe and moderate congenital hypothyroidism (CH) among 3 different initial L-thyroxine doses and to examine the effect of the time to thyroid function normalization on neurodevelopmental outcomes. Study design: Neurodevelopmental assessments of 31 subjects included the Mullen Scales of Early Learning, Wechsler Preschool and Primary Scale of Intelligence-Revised, Wechsler Intelligence Scale for Children, Wide-Range Achievement Test, and Child Behavioral Checklist. Results: Subjects started on higher initial L-thyroxine doses (50 μg) had full-scale IQ scores 11 points higher than those started on lower (37.5 μg) initial doses. However, verbal IQ, performance IQ, and achievement scores did not differ among the 3 treatment cohorts. Subjects with moderate CH had higher full-scale IQ scores than subjects with severe CH, regardless of the initial treatment dose. Subjects who took longer than 2 weeks to normalize thyroid function had significantly lower cognitive, attention, and achievement scores than those who achieved normal thyroid function at 1 or 2 weeks of therapy. Conclusions: Initial L-thyroxine dose and faster time to normalization of thyroid function are important to optimal neurodevelopmental outcome. In severe CH, it is important to choose an initial dose at the higher end of the recommended range to achieve these goals.

AB - Objectives: To compare neurodevelopmental outcomes in severe and moderate congenital hypothyroidism (CH) among 3 different initial L-thyroxine doses and to examine the effect of the time to thyroid function normalization on neurodevelopmental outcomes. Study design: Neurodevelopmental assessments of 31 subjects included the Mullen Scales of Early Learning, Wechsler Preschool and Primary Scale of Intelligence-Revised, Wechsler Intelligence Scale for Children, Wide-Range Achievement Test, and Child Behavioral Checklist. Results: Subjects started on higher initial L-thyroxine doses (50 μg) had full-scale IQ scores 11 points higher than those started on lower (37.5 μg) initial doses. However, verbal IQ, performance IQ, and achievement scores did not differ among the 3 treatment cohorts. Subjects with moderate CH had higher full-scale IQ scores than subjects with severe CH, regardless of the initial treatment dose. Subjects who took longer than 2 weeks to normalize thyroid function had significantly lower cognitive, attention, and achievement scores than those who achieved normal thyroid function at 1 or 2 weeks of therapy. Conclusions: Initial L-thyroxine dose and faster time to normalization of thyroid function are important to optimal neurodevelopmental outcome. In severe CH, it is important to choose an initial dose at the higher end of the recommended range to achieve these goals.

UR - http://www.scopus.com/inward/record.url?scp=28844454531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28844454531&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2005.07.024

DO - 10.1016/j.jpeds.2005.07.024

M3 - Article

VL - 147

SP - 775

EP - 780

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -